Pentixapharm says shareholders exercise rights for 9,096,771 new shares in capital raise

• Pentixapharm completed a rights offering tied to its capital increase, with subscription rights exercised for 9,096,771 new shares.
• The take-up rate reached 82.5% of the planned issuance, including oversubscription.
• Gross proceeds from the rights offering totaled about EUR 16.8 million.
• 1,923,441 unsubscribed new shares remain, offered to institutional investors via private placement through July 28 at EUR 1.85 each.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pentixapharm Holding AG published the original content used to generate this news brief via EQS News (Ref. ID: adhoc_2369974_en) on July 22, 2026, and is solely responsible for the information contained therein.